DRDO's anti-Covid drug 2-DG: Second batch of 10,000 packets to be released tomorrow

- The anti-COVID therapeutic application of the drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of the DRDO, in collaboration with Dr Reddy''s Laboratories (DRL) in Hyderabad